BLI’s unique and highly differentiated cell selection platform enables and accelerates the development and commercialization of biological therapies and other cell-based products through digital cell biology.
Berkeley Lights Inc.
20/01/2022
Related articles
Beyond Meat Inc.
01/12/2022
Beyond Meat Inc. - BYND - When the company went public in 2019, its shares skyrocketed as investors bet that the meatless movement was finally having its moment. During the...
Read More >>>Roche – an exquisite product pipeline
07/04/2022
Roche has an exquisite product pipeline full of innovation. This provides replacement power for outgoing patents and will nourish future growth in terms of sales and eps. Roche has it...
Read More >>>Omnicell, Inc.
20/01/2022
Omnicell, Inc., a leading developer and marketer of end-to-end automation solutions for the medication-use process, has a market cap of $3.06 billion. The company has an expected earnings growth rate...
Read More >>>NeoGenomics
20/01/2022
NEO has high potential to convert on fundamental momentum that has garnered speed over the previous 5-10 years into the coming periods. The market discounts NEO shares away from their...
Read More >>>YETI Holdings, Inc
20/01/2022
YETI Holdings, Inc. Is a leisure and recreation products company and therefore belongs to a sector with gaining traction.
Read More >>>